You are currently viewing a new version of our website. To view the old version click .
by
  • Victoria Rollason1,2,*,
  • Célia Lloret-Linares3 and
  • Kuntheavy Ing Lorenzini1,2
  • et al.

Reviewer 1: Anonymous Reviewer 2: Anonymous Reviewer 3: Anonymous

Round 1

Reviewer 1 Report

Dear Authors,

Thank you for provising me with the oppurtunity to review your article. Generally, the quality of prsentation of the article is fine and the following comments can help you to improve its quality of presentation:

Please start the methods section with the recognition of the research design, in connection to the previously published research.

Ethical considerations applying to the research process should be fully described under a separate subheading.

Please make the figure colourful.

Good luck!

Author Response

Dear Reviewer, 

Thank you for your suggestions that have been very helpful. Please find below a point-by point answer:

Please start the methods section with the recognition of the research design, in connection to the previously published research.

Line 75-77. The paragraph "2.1. Patients and setting" was reorganised to mention the design of the study, with reference to the previously published study at the beginning of the paragraph.

Ethical considerations applying to the research process should be fully described under a separate subheading

Line 96-97. Ethical considerations were moved to a separate paragraph at the end of "2.1. Patients and setting" subheading

Please make the figure colourful

Line 244. This was done, we hope it looks better

Thank you again and kind regards

Reviewer 2 Report

Thw work is very interesting and well defined.I have only two minor requests

1) Improve the quality of Figure 1.

2) Improve the future perspetives in conclusions to underline the importance of obtained results.

Author Response

Dear Reviewer,

Thank you very much for your helpful suggestions. Please find below a point-by-point answer to your comments: 

Improve the quality of Figure 1

Line 244. This was done, we hope it looks better

Improve the future perspectives in conclusions to underline the importance of obtained results

Line 336-358. The conclusion and perspectives were improved

 Thank you again and kind regards

Reviewer 3 Report

This is a retrospective study in personalized medicine field and it reveals pharmacogenetic impact in adverse drug response and pharmacological resistance in patients taking analgesic drugs for chronic pain. In my opinion this study is of interest, clearly organized and well described, with novelty aspects. I think there is a bit of sorting out the description of enzymes you have investigated and it would be worth to indicate phase I, phase II enzymes and transporters. Additionally, it would be interested to shortly describe the involvement of studied enzymes in the metabolizing of given analgesic drug(s).

Author Response

Dear Reviewer,

Thank you very much for your helpful suggestions. Please find below a point-by-point answer to your comments:

This is a retrospective study in personalized medicine field and it reveals pharmacogenetic impact in adverse drug response and pharmacological resistance in patients taking analgesic drugs for chronic pain. In my opinion this study is of interest, clearly organized and well described, with novelty aspects. I think there is a bit of sorting out the description of enzymes you have investigated and it would be worth to indicate phase I, phase II enzymes and transporters.

Line 119-123. We clarified this in the section 2.3 by adding a paragraph better explaining the enzymes.

Additionally, it would be interested to shortly describe the involvement of studied enzymes in the metabolizing of given analgesic drug(s).

Line 121-126. We added a table describing the metabolic pathways of the analgesics regarding CYPs and a text explaining the COMT and P-gp.

Thank you again and kind regards